$3.83
-0.11-2.79%
At Close: -
$3.77
-0.06-1.57%
After Hours: 5:01 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Puma Biotechnology (NASDAQ:PBYI) Stock, Analyst Ratings, Price Targets, Forecasts
Puma Biotechnology Inc has a consensus price target of $7 based on the ratings of 4 analysts. The high is $8 issued by Goldman Sachs on August 6, 2021. The low is $6 issued by RBC Capital on August 6, 2021. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 26, 2024, June 4, 2024, and June 3, 2024, respectively. With an average price target of $7 between HC Wainwright & Co., there's an implied 85.68% upside for Puma Biotechnology Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
RBC Capital
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Puma Biotechnology
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/26/2024 | Buy Now | 85.68% | HC Wainwright & Co. | Edward White | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 85.68% | HC Wainwright & Co. | Edward White | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 85.68% | HC Wainwright & Co. | Edward White | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/20/2024 | Buy Now | 85.68% | HC Wainwright & Co. | Edward White | → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2024 | Buy Now | 85.68% | HC Wainwright & Co. | Edward White | → $7 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | Buy Now | 85.68% | HC Wainwright & Co. | Edward White | $8 → $7 | Maintains | Buy | Get Alert |
| 02/13/2024 | Buy Now | 112.2% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 09/20/2023 | Buy Now | 112.2% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | Buy Now | 112.2% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 112.2% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | Buy Now | 112.2% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 03/06/2023 | Buy Now | 112.2% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 08/05/2022 | Buy Now | 112.2% | HC Wainwright & Co. | Edward White | $12 → $8 | Maintains | Buy | Get Alert |
| 05/06/2022 | Buy Now | 218.3% | HC Wainwright & Co. | Edward White | $14 → $12 | Maintains | Buy | Get Alert |
| 09/28/2021 | Buy Now | — | Citigroup | — | — | Upgrade | Neutral → Buy | Get Alert |
| 08/06/2021 | Buy Now | 59.15% | RBC Capital | Kennen MacKay | — | Maintains | Sector Perform | Get Alert |
| 08/06/2021 | Buy Now | 112.2% | Goldman Sachs | — | — | Maintains | Sell | Get Alert |
FAQ
What is the target price for Puma Biotechnology (PBYI) stock?
The latest price target for Puma Biotechnology (NASDAQ:PBYI) was reported by HC Wainwright & Co. on July 26, 2024. The analyst firm set a price target for $7.00 expecting PBYI to rise to within 12 months (a possible 85.68% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Puma Biotechnology (PBYI)?
The latest analyst rating for Puma Biotechnology (NASDAQ:PBYI) was provided by HC Wainwright & Co., and Puma Biotechnology reiterated their buy rating.
When was the last upgrade for Puma Biotechnology (PBYI)?
The last upgrade for Puma Biotechnology Inc happened on September 28, 2021 when Citigroup raised their price target to N/A. Citigroup previously had a neutral for Puma Biotechnology Inc.
When was the last downgrade for Puma Biotechnology (PBYI)?
There is no last downgrade for Puma Biotechnology.
When is the next analyst rating going to be posted or updated for Puma Biotechnology (PBYI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Puma Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Puma Biotechnology was filed on July 26, 2024 so you should expect the next rating to be made available sometime around July 26, 2025.
Is the Analyst Rating Puma Biotechnology (PBYI) correct?
While ratings are subjective and will change, the latest Puma Biotechnology (PBYI) rating was a reiterated with a price target of $7.00 to $7.00. The current price Puma Biotechnology (PBYI) is trading at is $3.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.